Oncotarget
The cover of the October issue of Oncotarget features the first figure from Couty et al. showing chimera and native PKA-S6K1.
In vivo selection of tumor-specific antibodies |
https://doi.org/10.18632/oncotarget.1407 David Sánchez-Martín, Laura Sanz, Erkki Ruoslahti, and Luis Alvarez-Vallina |
1547 |
PDF | HTML | How to cite | Order a Reprint |
Estrogen response in luminal breast cancer |
https://doi.org/10.18632/oncotarget.1354 Leticia B A Rangel, and Tim Hui-Ming Huang |
1548-1549 |
PDF | HTML | How to cite | Order a Reprint |
IκBα beyond the NF-kB dogma |
https://doi.org/10.18632/oncotarget.1325 María Carmen Mulero, Anna Bigas, and Lluís Espinosa |
1550-1551 |
PDF | HTML | How to cite | Order a Reprint |
Cytokine-induced ‘bystander’ senescence in DDR and immuno-surveillance |
https://doi.org/10.18632/oncotarget.1487 Zdenek Hodny, Sona Hubackova, and Jiri Bartek |
1552-1553 |
PDF | HTML | How to cite | Order a Reprint |
Ribosomes: the future of targeted therapies? |
https://doi.org/10.18632/oncotarget.1511 Virginie Marcel, Frédéric Catez, and Jean-Jacques Diaz |
1554-1555 |
PDF | HTML | How to cite | Order a Reprint |
Lysine-specific modifications of p53: a matter of life and death? |
https://doi.org/10.18632/oncotarget.1436 Diana Marouco, Alexander V Garabadgiu, Gerry Melino, and Nick A Barlev |
1556-1571 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy |
https://doi.org/10.18632/oncotarget.1157 Laura Bonanno, Carlota Costa, Margarita Majem, Jose Javier Sanchez, Ana Gimenez-Capitan, Ignacio Rodriguez, Alain Vergenegre, Bartomeu Massuti, Adolfo Favaretto, Massimo Rugge, Cinta Pallares, Miquel Taron, and Rafael Rosell |
1572-1581 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients |
https://doi.org/10.18632/oncotarget.1050 Marc Delord, Philippe Rousselot, Jean-Michel Cayuela, François Sigaux, Joëlle Guilhot, Claude Preudhomme, François Guilhot, Pascale Loiseau, Emmanuel Raffoux, Daniela Geromin, Emmanuelle Genin, Fabien Calvo, and Heriberto Bruzzoni-Giovanelli |
1582-1591 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer |
https://doi.org/10.18632/oncotarget.1148 Alexandra Canonici, Merel Gijsen, Maeve Mullooly, Ruth Bennett, Noujoude Bouguern, Kasper Pedersen, Neil A O’Brien, Ioannis Roxanis, Ji-Liang Li, Esther Bridge, Richard Finn, Dennis Slamon, Patricia McGowan, Michael J. Duffy, Norma O’Donovan, John Crown, and Anthony Kong |
1592-1605 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Small-molecule targeting of translation initiation for cancer therapy |
https://doi.org/10.18632/oncotarget.1186 Bertal H. Aktas, Yuan Qiao, Esra Ozdelen, Roland Schubert, Sema Sevinc, Fred Harbinski, Luciano Grubissich, Samuel Singer, and Jose A. Halperin |
1606-1617 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.1221 Catia Giovannini, Michele Baglioni, Marco Baron Toaldo, Cristiano Ventrucci, Stefania D'Adamo, Mario Cipone, Pasquale Chieco, Laura Gramantieri, and Luigi Bolondi |
1618-1631 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth |
https://doi.org/10.18632/oncotarget.1365 Elena Kurenova, Jianqun Liao, Di-Hua He, Darrell Hunt, Michael Yemma, Wiam Bshara, Mukund Seshadri, and William G Cance |
1632-1646 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design |
https://doi.org/10.18632/oncotarget.1255 Sylvain Couty, Isaac M. Westwood, Andrew Kalusa, Celine Cano, Jon Travers, Kathy Boxall, Chiau Ling Chow, Sam Burns, Jessica Schmitt, Lisa Pickard, Caterina Barillari, P. Craig McAndrew, Paul A. Clarke, Spiros Linardopoulos, Roger J. Griffin, G. Wynne Aherne, Florence I. Raynaud, Paul Workman, Keith Jones, and Rob L.M. van Montfort |
1647-1661 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Press Release | Order a Reprint |
HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma |
https://doi.org/10.18632/oncotarget.1232 Bryce P Portier, Eugen C. Minca, Zhen Wang, Christopher Lanigan, Aaron M. Gruver, Erinn Downs-Kelly, G. Thomas Budd, and Raymond R. Tubbs |
1662-1672 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer |
https://doi.org/10.18632/oncotarget.1237 Tiago Baptista, Inês Graça, Elsa J Sousa, Ana I Oliveira, Natália R Costa, Pedro Costa-Pinheiro, Francisco Amado, Rui Henrique, and Carmen Jeronimo |
1673-1685 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration |
https://doi.org/10.18632/oncotarget.1265 Sandra Cascio, Adam M Farkas, Rebecca P Hughey, and Olivera J Finn |
1686-1697 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Lung cancer tumorigenicity and drug resistance are maintained through ALDHhi CD44hi tumor initiating cells |
https://doi.org/10.18632/oncotarget.1246 Jing Liu, Zhijie Xiao, Sunny Kit-Man Wong, Vicky Pui-Chi Tin, Ka-Yan Ho, Junwen Wang, Mai-Har Sham, and Maria Pik Wong |
1698-1711 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.1280 Riccardo Masetti, Marco Togni, Annalisa Astolfi, Martina Pigazzi, Elena Manara, Valentina Indio, Carmelo Rizzari, Sergio Rutella, Giuseppe Basso, Andrea Pession, and Franco Locatelli |
1712-1720 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma |
https://doi.org/10.18632/oncotarget.1379 Andrea Treszl, Zita Steiber, Andrew V Schally, Norman L Block, Balazs Dezso, Gabor Olah, Bernadett Rozsa, Klara Fodor, Armin Buglyo, Janos Gardi, Andras Berta, and Gabor Halmos |
1721-1728 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine. |
https://doi.org/10.18632/oncotarget.1412 Sevin Turcan, Armida WM Fabius, Alexandra Borodovsky, Alicia Pedraza, Cameron Brennan, Jason Huse, Agnes Viale, Gregory J Riggins, and Timothy A Chan |
1729-1736 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft |
https://doi.org/10.18632/oncotarget.1408 Alexandra Borodovsky, Vafi Salmasi, Sevin Turcan, Armida W. M. Fabius, Gilson Baia, Charles G Eberhart, Jon D. Weingart, Gary L Gallia, Stephen B Baylin, Timothy A Chan, and Gregory J Riggins |
1737-1747 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations |
https://doi.org/10.18632/oncotarget.1292 Roxana S Redis, Anieta M Siewerts, Maxime P Look, Oana Tudoran, Cristina Ivan, Riccardo Spizzo, Xinna Zhang, Vanja de Weerd, Masayoshi Shimizu, Hui Ling, Rares Buiga, Victor Pop, Alexandru Irimie, Riccardo Fodde, Isabella Bedrosian, John WM Martens, John A Foekens, Ioana Berindan-Neagoe, and George A Calin |
1748-1762 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Identification of novel small molecule inhibitors of centrosome clustering in cancer cells |
https://doi.org/10.18632/oncotarget.1198 Eiko Kawamura, Andrew B. Fielding, Nagarajan Kannan, Aruna Balgi, Connie J. Eaves, Michel Roberge, and Shoukat Dedhar |
1763-1776 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine |
https://doi.org/10.18632/oncotarget.1295 Duane H. Hamilton, Mary T. Litzinger, Alessandra Jales, Bruce Huang, Romaine I. Fernando, James W. Hodge, Andressa Ardiani, David Apelian, Jeffrey Schlom, and Claudia Palena |
1777-1790 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathway |
https://doi.org/10.18632/oncotarget.1324 Seung-Hyun Hong, Sung-Ho Goh, Sang-Jin Lee, Jung-Ah Hwang, Jieun Lee, Il-Ju Choi, Hyehyun Seo, Jong-Hoon Park, Hiromu Suzuki, Eiichiro Yamamoto, In-Hoo Kim, Jin Sook Jeong, Mi Ha Ju, Dong-Hee Lee, and Yeon-Su Lee |
1791-1803 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation |
https://doi.org/10.18632/oncotarget.1364 Jing Liu, Aimin Xu, Karen Siu-Ling Lam, Nai-Sum Wong, Jie Chen, Peter R R Shepherd, and Yu Wang |
1804-1818 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation |
https://doi.org/10.18632/oncotarget.1312 Xiaoping Wu, Huixian Huang, Cong Wang, Shaoqiang Lin, Yadong Huang, Yi Wang, Guang Liang, Qiuxia Yan, Jian Xiao, Jianzhang Wu, Yongguang Yang, and Xiaokun Li |
1819-1828 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector |
https://doi.org/10.18632/oncotarget.1397 Franco Venanzi, Victor Shifrin, Michael Y. Sherman, Vladimir Gabai, Oleg Kisilev, Andrey Komissarov, Mikhail Grudinin, Maria Shartakova, Ekaterina Romanovskaya-Romanko, Yuri Kudryavets, Natalya Bezdenezhnykh, Oleksandra Lykhova, Nadiia Semesyuk, Antonio Concetti, Anatoly Tsyb, Marina Filimonova, Victoria Makarchuk, Raisa Yakubovsky, Andrey Chursov, Vita Shcherbinina, and Alexander Shneider |
1829-1835 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis |
https://doi.org/10.18632/oncotarget.1282 Cheryl McFarlane, Suzanne McFarlane, Ian Paul, Kenneth Arthur, Michael Scheaff, Keith Kerr, Michael Stevenson, Dean A Fennell, and James A Johnston |
1836-1843 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis |
https://doi.org/10.18632/oncotarget.1300 Zeyad D Nassar, Hyeongsun Moon, Tam Duong, LiQi Neo, Michelle M Hill, Mathias Francois, Robert G Parton, and Marie-Odile Parat |
1844-1855 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA |
https://doi.org/10.18632/oncotarget.1486 Luis A. Diaz, Jr, Mark Sausen, George A. Fisher, and Victor E. Velculescu |
1856-1857 |
PDF | HTML | How to cite | Order a Reprint |
Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC